Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant-Reference-Cited by-同舟云学术

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

Published:2010-08-02 Issue:8 Volume:120 Page:2715-2730
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Sun Shihua,Sprenger Cynthia C.T.,Vessella Robert L.,Haugk Kathleen,Soriano Kathryn,Mostaghel Elahe A.,Page Stephanie T.,Coleman Ilsa M.,Nguyen Holly M.,Sun Huiying,Nelson Peter S.,Plymate Stephen R.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference52 articles.

1. Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis

2. Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding

Cited by 611 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting proliferating cell nuclear antigen enhances ionizing radiation‐induced cytotoxicity in prostate cancer cells;The Prostate;2024-09

2. Computational Analysis of Treatment Resistant Cancer Cells;2024-08-31

3. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06

4. Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Therapy: A Review of Implications for Anti-androgen Treatment Strategies and Resistance;Cureus;2024-07-24

5. Androgen receptor and estrogen receptor variants in prostate and breast cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-07